Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells.
暂无分享,去创建一个
A. Sette | E. Appella | R. Kiessling | T. Nakazawa | E. Celis | F. Salazar-Onfray | S. Southwood | G. Masucci | K. Kärre | V. Chhajlani | M. Petersson | E. Celis | Ettore Appella | Rolf Kiessling | Flavio Salazar-Onfray | Alessandro Sette | Tsutomu Nakazawa | Giuseppe Masucci | Vijay Chhajlani | Max Petersson
[1] A Sette,et al. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.
[2] A. Anichini,et al. Multiple melanoma-associated epitopes recognized by HLA-A3-restricted CTLs and shared by melanomas but not melanocytes. , 1996, Journal of immunology.
[3] F. Marincola,et al. Binding and presentation of peptides derived from melanoma antigens MART-1 and glycoprotein-100 by HLA-A2 subtypes. Implications for peptide-based immunotherapy. , 1996, Journal of immunology.
[4] V. Chhajlani. Distribution of cDNA for melanocortin receptor subtypes in human tissues. , 1996, Biochemistry and molecular biology international.
[5] J. Wikberg,et al. Immunological localisation of melanocortin 1 receptor on the cell surface of WM266-4 human melanoma cells. , 1996, Cancer letters.
[6] J. Wikberg,et al. Molecular cloning of a novel human melanocortin receptor. , 1993, Biochemical and biophysical research communications.
[7] M. Serrano,et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.
[8] J. Wharton,et al. Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines , 1995, The Journal of experimental medicine.
[9] W. Kast,et al. Induction and characterization of cytotoxic T‐lymphocytes recognizing a mutated p21ras peptide presented by HLA‐A*0201 , 1995, International journal of cancer.
[10] A. Sette,et al. Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression. , 1995, Journal of immunology.
[11] A Sette,et al. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1. , 1995, Journal of immunology.
[12] A. Vitiello,et al. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. , 1994, Journal of immunology.
[13] K. Sakaguchi,et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[14] K. Sakaguchi,et al. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes , 1994, The Journal of experimental medicine.
[15] J. Renauld,et al. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1994, The Journal of experimental medicine.
[16] S. H. van der Burg,et al. p53, a potential target for tumor-directed T cells. , 1994, Immunology letters.
[17] R. Henderson,et al. Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines. , 1994, Science.
[18] S. Rosenberg,et al. Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[19] A Sette,et al. Definition of specific peptide motifs for four major HLA-A alleles. , 1994, Journal of immunology.
[20] P. Romero,et al. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes , 1994, The Journal of experimental medicine.
[21] S. H. van der Burg,et al. In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild‐type p53 , 1993, European journal of immunology.
[22] P. Coulie,et al. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas , 1993, The Journal of experimental medicine.
[23] S. Watson,et al. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. , 1993, The Journal of biological chemistry.
[24] S. Watson,et al. Molecular cloning of a novel melanocortin receptor. , 1993, The Journal of biological chemistry.
[25] K. Parker,et al. Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2. , 1992, Journal of immunology.
[26] J. Wikberg,et al. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA , 1992, FEBS letters.
[27] A. Thody,et al. Alpha-melanocyte-stimulating hormone stimulates protein kinase C activity in murine B16 melanoma. , 1992, The Journal of endocrinology.
[28] J. Lunec,et al. MSH receptor expression and the relationship to melanogenesis and metastatic activity in B16 melanoma , 1992, Melanoma research.
[29] P. Parham,et al. The HLA-A,B "negative" mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. , 1992, Journal of immunology.
[30] P. Chomez,et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. , 1991, Science.
[31] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[32] M. Atkins,et al. Melanotropin receptors demonstrated in situ in human melanoma. , 1990, The Journal of clinical investigation.
[33] G. Ghanem,et al. Alpha-melanocyte-stimulating hormone immunoreactivity in human melanoma metastases extracts. , 1989, Pigment cell research.
[34] V. Hearing,et al. Regulation of mammalian melanogenesis by tyrosinase inhibition. , 1989, Differentiation; research in biological diversity.
[35] M. Hansen,et al. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. , 1989, Journal of immunological methods.
[36] D. Bennett. Mechanisms of differentiation in melanoma cells and melanocytes. , 1989, Environmental health perspectives.
[37] P. Cresswell,et al. Impaired assembly and transport of HLA‐A and ‐B antigens in a mutant TxB cell hybrid. , 1986, The EMBO journal.
[38] S. Pomerantz,et al. Regulation of tyrosinase in human melanocytes grown in culture , 1983, The Journal of cell biology.